Talis Biomedical Corp Quarterly Assets in USD from Q4 2020 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Talis Biomedical Corp quarterly Assets history and growth rate from Q4 2020 to Q2 2024.
Talis Biomedical Corp Assets for the quarter ending June 30, 2024 was $72.7M, a 40.9% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2024	$72.7M	-$50.4M	-40.9%	Jun 30, 2024	10-Q	2024-08-19
Q1 2024	$82.5M	-$50.6M	-38%	Mar 31, 2024	10-Q	2024-05-08
Q4 2023	$94.7M	-$74.6M	-44.1%	Dec 31, 2023	10-Q	2024-08-19
Q3 2023	$107M	-$86.9M	-44.8%	Sep 30, 2023	10-Q	2023-11-14
Q2 2023	$123M	-$98.6M	-44.5%	Jun 30, 2023	10-Q	2023-08-10
Q1 2023	$133M	-$97.5M	-42.3%	Mar 31, 2023	10-Q	2023-05-11
Q4 2022	$169M	-$96.5M	-36.3%	Dec 31, 2022	10-K	2024-03-28
Q3 2022	$194M	-$109M	-36%	Sep 30, 2022	10-Q	2022-11-03
Q2 2022	$222M	-$158M	-41.6%	Jun 30, 2022	10-Q	2022-08-02
Q1 2022	$231M	-$173M	-42.8%	Mar 31, 2022	10-Q	2022-05-10
Q4 2021	$266M	+$67.4M	+34%	Dec 31, 2021	10-K	2023-03-22
Q3 2021	$303M			Sep 30, 2021	10-Q	2021-11-16
Q2 2021	$380M			Jun 30, 2021	10-Q	2021-08-10
Q1 2021	$403M			Mar 31, 2021	10-Q	2021-05-13
Q4 2020	$198M			Dec 31, 2020	10-K	2022-03-15

* An asterisk sign (*) next to the value indicates that the value is likely invalid.